Mitochondrial inner membrane and mitochondrial matrix (MIM/Matrix)

The mitochondrial inner membrane (MIM) and mitochondrial matrix constitute the core metabolic engine of the cell, responsible for the majority of cellular adenosine triphosphate (ATP) production through oxidative phosphorylation [1]. The MIM is a highly specialized, protein-rich lipid bilayer that houses the electron transport chain (ETC) complexes and ATP synthase [2]. Enclosed by the MIM, the matrix contains the enzymes of the tricarboxylic acid (TCA) cycle, mitochondrial DNA, and the machinery for fatty acid beta-oxidation [3]. Although these compartments are cellular locations rather than single molecular targets, they are the site of action for numerous drugs aimed at modulating energy metabolism and cell death pathways [4]. Dysregulation of mitochondrial processes in these areas is implicated in a wide range of pathologies, including neurodegenerative diseases, metabolic syndromes, and ischemia-reperfusion injury [5]. Therapeutic strategies often involve the use of small molecules to stabilize mitochondrial membranes, inhibit specific ETC complexes, or neutralize reactive oxygen species generated within the matrix [6]. For example, metformin acts on Complex I in the MIM, while antioxidants like MitoQ target the matrix to reduce oxidative stress [7, 9]. Consequently, these compartments are critical focal points for drug development in aging, oncology, and metabolic health [8].

Other names

Mitochondrial interiorInner mitochondrial compartmentMitochondrial cristae and matrixMIM and matrix

Modulation of the electron transport chain complexes, uncoupling of oxidative phosphorylation, stabilization of mitochondrial membranes (e.g., cardiolipin), or scavenging of matrix-localized reactive oxygen species [6, 7, 9, 12].